As of March 29, 2025, the latest update on 23andMe is that the company has voluntarily filed for Chapter 11 bankruptcy protection on March 23, 2025, to facilitate a court-supervised sale process aimed at maximizing its business value. This filing follows financial struggles, including a 12% revenue dip reported in November 2024 and the rejection of a non-binding acquisition offer from CEO Anne Wojcicki and her affiliates. On March 26, 2025, 23andMe received court approval for its "first day" motions, allowing it to continue business operations as usual during the bankruptcy process. The company has secured approximately $35 million in debtor-in-possession financing to support ongoing operations.
23andMe intends to remain operational, with no immediate changes to how it stores, manages, or protects customer data. It is actively seeking a buyer who will uphold its commitment to customer data privacy and further its mission of helping people understand their genetic information. This development has raised concerns about the future of the genetic data of its 15 million customers, prompting California Attorney General Rob Bonta to warn users to consider deleting their data due to potential privacy risks in the event of a sale. Customers can still access their accounts and genetic reports, and the option to delete data remains available through account settings. For more details, 23andMe has directed users to its dedicated restructuring website and press releases issued on March 23 and March 26, 2025. 17GEN4.com
Comments